The renin-angiotensin-aldosterone system in pre-eclampsia: The delicate balance between good and bad

Clinical Science

Volumn 126, Issue 8, 2014, Pages 537-544

  Verdonk, Koen ^a   Visser, Willy ^a   Van Den Meiracker, Anton H ^a   Danser, A H Jan ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Aldosterone; Autoantibody; Pre eclampsia; Prorenin; Renin; Renin angiotensin aldosterone system (RAAS); Soluble fms like tyrosine kinase 1 (sFlt 1); Vascular endothelial growth factor (VEGF)

Indexed keywords

ALDOSTERONE; ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSIN II [3-8]; ANGIOTENSIN III; ANGIOTENSIN V; ANGIOTENSIN VI; ANGIOTENSIN VII; ANGIOTENSINOGEN; PRORENIN; RECEPTOR ANTIBODY; RENIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; HEMODYNAMICS; NONHUMAN; PATHOGENESIS; PREECLAMPSIA; PREGNANCY; PRESSOR RESPONSE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYNTHESIS;

EID: 84892449729     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20130455     Document Type: Article

References (62)

1. Steegers, E. A., von Dadelszen, P., Duvekot, J. J. and Pijnenborg, R. (2010) Pre-eclampsia. Lancet 376, 631-644
2. Verlohren, S., Stepan, H. and Dechend, R. (2012) Angiogenic growth factors in the diagnosis and prediction of pre-eclampsia. Clin. Sci. 122, 43-52
3. Rana, S., Powe, C. E., Salahuddin, S., Verlohren, S., Perschel, F. H., Levine, R. J., Lim, K. H., Wenger, J. B., Thadhani, R. and Karumanchi, S. A. (2012) Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia. Circulation 125, 911-919
4. Verdonk, K., Visser, W., Russcher, H., Danser, A. H. J., Steegers, E. A. P. and van den Meiracker, A. H. (2012) Differential diagnosis of preeclampsia remember the soluble fms-like tyrosine kinase 1/placental growth factor ratio. Hypertension 60, 884-890
5. Gilbert, J. S., Babcock, S. A. and Granger, J. P. (2007) Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble fms-like tyrosine kinase-1 expression. Hypertension 50, 1142-1147
6. Maynard, S. E., Min, J. Y., Merchan, J., Lim, K. H., Li, J., Mondal, S., Libermann, T. A., Morgan, J. P., Sellke, F. W., Stillman, I. E. et al. (2003) Excess placental soluble fms-like tyrosine kinase 1 (sflt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J. Clin. Invest. 111, 649-658
7. Herse, F., Dechend, R., Harsem, N. K., Wallukat, G., Janke, J., Qadri, F., Hering, L., Muller, D. N., Luft, F. C. and Staff, A. C. (2007) Dysregulation of the circulating and tissue-based renin-angiotensin system in preeclampsia. Hypertension 49, 604-611
8. Williams, D. J., Vallance, P. J. T., Neild, G. H., Spencer, J. A. D. and Imms, F. J. (1997) Nitric oxide-mediated vasodilation in human pregnancy. Am. J. Physiol. 272, H748-H752
9. Brown, M. A. and Gallery, E. D. (1994) Volume homeostasis in normal pregnancy and pre-eclampsia: physiology and clinical implications. Baillieres Clin. Obstet. Gynaecol. 8, 287-310
10. Moran, P., Lindheimer, M. D. and Davison, J. M. (2004) The renal response to preeclampsia. Semin. Nephrol. 24, 588-595
11. Salas, S. P., Marshall, G., Gutierrez, B. L. and Rosso, P. (2006) Time course of maternal plasma volume and hormonal changes in women with preeclampsia or fetal growth restriction. Hypertension 47, 203-208
12. Visser, W. and Wallenburg, H. C. S. (1991) Central hemodynamic observations in untreated preeclamptic patients. Hypertension 17, 1072-1077
13. Tewksbury, D. A. (1996) Quantitation of five forms of high molecular weight angiotensinogen from human placenta. Am. J. Hypertens. 9, 1029-1034
14. Tewksbury, D. A. and Dart, R. A. (1982) High molecular-weight angiotensinogen levels in hypertensive pregnant-women. Hypertension 4, 729-734
15. Kloverpris, S., Skov, L. L., Glerup, S., Pihl, K., Christiansen, M. and Oxvig, C. (2013) Formation of high-molecular-weight angiotensinogen during pregnancy is a result of competing redox reactions with the proform of eosinophil major basic protein. Biochem. J. 449, 209-217
16. Brown, M. A., Nicholson, E. and Gallery, E. D. M. (1988) Sodium renin aldosterone relations in normal and hypertensive pregnancy. Br. J. Obstet. Gynaecol. 95, 1237-1246
17. Zhou, A. W., Carrell, R. W., Murphy, M. P., Wei, Z. Q., Yan, Y. H., Stanley, P. L. D., Stein, P. E., Pipkin, F. B. and Read, R. J. (2010) A redox switch in angiotensinogen modulates angiotensin release. Nature 468, 108-111
18. Batenburg, W. W., Krop, M., Garrelds, I. M., de Vries, R., de Bruin, R. J., Burcklé, C. A., Müller, D. N., Bader, M., Nguyen, G. and Danser, A. H. J. (2007) Prorenin is the endogenous agonist of the (pro)renin receptor. Binding kinetics of renin and prorenin in rat vascular smooth muscle cells overexpressing the human (pro) renin receptor. J. Hypertens. 25, 2441-2453
19. Shahvaisizadeh, F., Movafagh, A., Omrani, M. D., Vaisi-Raygani, A., Rahimi, Z. and Rahimi, Z. (2012) Synergistic effects of angiotensinogen-217 G?A and T704C (M235T) variants on the risk of severe preeclampsia. JRAAS, doi:10.1177/ 1470320312467555
20. Danser, A. H. J., Derkx, F. H. M., Schalekamp, M. A. D. H., Hense, H. W., Riegger, G. A. J. and Schunkert, H. (1998) Determinants of interindividual variation of renin and prorenin concentrations: evidence for a sexual dimorphism of (pro)renin levels in humans. J. Hypertens. 16, 853-862
21. Morgan, T. K., Rohrwasser, A., Zhao, L., Hillas, E., Cheng, T., Ward, K. J. and Lalouel, J. M. (2006) Hypervolemia of pregnancy is not maintained in mice chronically overexpressing angiotensinogen. Am. J. Obstet. Gynecol. 195, 1700-1706
22. Takimoto, E., Ishida, J., Sugiyama, F., Horiguchi, H., Murakami, K. and Fukamizu, A. (1996) Hypertension induced in pregnant mice by placental renin and maternal angiotensinogen. Science 274, 995-998
23. Verlohren, S., Geusens, N., Morton, J., Verhaegen, I., Hering, L., Herse, F., Dudenhausen, J. W., Muller, D. N., Luft, F. C., Cartwright, J. E. et al. (2010) Inhibition of trophoblast-induced spiral artery remodeling reduces placental perfusion in rat pregnancy. Hypertension 56, 304-310
24. Bohlender, J., Ganten, D. and Luft, F. C. (2000) Rats transgenic for human renin and human angiotensinogen as a model for gestational hypertension. J. Am. Soc. Nephrol. 11, 2056-2061
25. Derkx, F. H. M., Alberda, A. T., de Jong, F. H., Zeilmaker, F. H., Makovitz, J. W. and Schalekamp, M. A. D. H. (1987) Source of plasma prorenin in early and late pregnancy: observations in a patient with primary ovarian failure. J. Clin. Endocrinol. Metab. 65, 349-354
26. Spaan, J. J. and Brown, M. A. (2012) Renin-angiotensin system in pre-eclampsia: everything old is new again. Obstet. Med. 5, 147-153
27. Krop, M. and Danser, A. H. J. (2008) Circulating versus tissue renin-angiotensin system: on the origin of (pro)renin. Curr. Hypertens. Reports 10, 112-118
28. Nguyen, G., Delarue, F., Burckle, C., Bouzhir, L., Giller, T. and Sraer, J. D. (2002) Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J. Clin. Invest. 109, 1417-1427
29. Batenburg, W. W., Lu, X., Leijten, F., Maschke, U., Muller, D. N. and Danser, A. H. J. (2011) Renin-and prorenin-induced effects in rat vascular smooth muscle cells overexpressing the human (pro)renin receptor: does (pro)renin-(pro)renin receptor interaction actually occur? Hypertension 58, 1111-1119
30. Ringholm, L., Pedersen-Bjergaard, U., Thorsteinsson, B., Boomsma, F., Damm, P. and Mathiesen, E. R. (2011) A high concentration of prorenin in early pregnancy is associated with development of pre-eclampsia in women with type 1 diabetes. Diabetologia 54, 1615-1619
31. Nochy, D., Bariety, J., Camilleri, J. P., Barres, D., Corvol, P. and Menard, J. (1984) Diminished number of renin-containing cells in kidney biopsy samples from hypertensive women immediately postpartum - an immunomorphologic study. Kidney Int. 26, 85-87
32. Miyamoto, S., Shimokawa, H., Sumioki, H., Touno, A. and Nakano, H. (1988) Circadian rhythm of plasma atrial natriuretic peptide, aldosterone, and blood pressure during the third trimester in normal and preeclamptic pregnancies. Am. J. Obstet. Gynecol. 158, 393-399
33. Kappers, M. H. W., van Esch, J. H. M., Sluiter, W., Sleijfer, S., Danser, A. H. J. and van den Meiracker, A. H. (2010) Hypertension induced by the tyrosine kinase inhibitor sunitinib is associated with increased circulating endothelin-1 levels. Hypertension 56, 675-681
34. Gant, N. F., Daley, G. L., Chand, S., Whalley, P. J. and MacDonald, P. C. (1973) A study of angiotensin II pressor response throughout primigravid pregnancy. J. Clin. Invest. 52, 2682-2689
35. Saxena, A. R., Karumanchi, S. A., Brown, N. J., Royle, C. M., McElrath, T. F. and Seely, E. W. (2010) Increased sensitivity to angiotensin II is present postpartum in women with a history of hypertensive pregnancy. Hypertension 55, 1239-1245
36. AbdAlla, S., Lother, H., el Massiery, A. and Quitterer, U. (2001) Increased At1 receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness. Nat. Med. 7, 1003-1009
37. Mishra, N., Nugent, W. H., Mahavadi, S. and Walsh, S. W. (2011) Mechanisms of enhanced vascular reactivity in preeclampsia. Hypertension 58, 867-873
38. Verdonk, K. and Danser, A. H. J. (2012) Reactive oxygen species and angiotensin ii response in human omental arteries: What about tachyphylaxis? Hypertension 59, e16
39. Wallukat, G., Homuth, V., Fischer, T., Lindschau, C., Horstkamp, B., Jupner, A., Baur, E., Nissen, E., Vetter, K., Neichel, D. et al. (1999) Patients with preeclampsia develop agonistic autoantibodies against the angiotensin At1 receptor. J. Clin. Invest. 103, 945-952
40. Siddiqui, A. H., Irani, R. A., Blackwell, S. C., Ramin, S. M., Kellems, R. E. and Xia, Y. (2010) Angiotensin receptor agonistic autoantibody is highly prevalent in preeclampsia correlation with disease severity. Hypertension 55, 386-393
41. Dechend, R., Muller, D. N., Wallukat, G., Homuth, V., Krause, M., Dudenhausen, J. and Luft, F. C. (2004) At1 receptor agonistic antibodies, hypertension, and preeclampsia. Semin. Nephrol. 24, 571-579
42. Herse, F., Verlohren, S., Wenzel, K., Pape, J., Muller, D. N., Modrow, S., Wallukat, G., Luft, F. C., Redman, C. W. G. and Dechend, R. (2009) Prevalence of agonistic autoantibodies against the angiotensin II type 1 receptor and soluble fms-like tyrosine kinase 1 in a gestational age-matched case study. Hypertension 53, 393-398
43. Stepan, H., Wallukat, G., Schultheiss, H. P., Faber, R. and Walther, T. (2007) Is parvovirus b19 the cause for autoimmunity against the angiotensin II type receptor? J. Reprod. Immunol. 73, 130-134
44. Langer, B., Grima, M., Coquard, C., Bader, A. M., Schlaeder, G. and Imbs, J. L. (1998) Plasma active renin, angiotensin I, and angiotensin II during pregnancy and in preeclampsia. Obstet. Gynecol. 91, 196-202
45. Bharadwaj, M. S., Strawn, W. B., Groban, L., Yamaleyeva, L. M., Chappell, M. C., Horta, C., Atkins, K., Firmes, L., Gurley, S. B. and Brosnihan, K. B. (2011) Angiotensin-converting enzyme 2 deficiency is associated with impaired gestational weight gain and fetal growth restriction. Hypertension 58, 852-858
46. Sykes, S. D., Pringle, K. G., Zhou, A., Dekker, G. A., Roberts, C. T. and Lumbers, E. R. (2013) Fetal sex and the circulating renin-angiotensin system during early gestation in women who later develop preeclampsia or gestational hypertension. J. Hum. Hypertens., doi:10.1038/jhh.2013.51
47. Machado, R. D. P., Santos, R. A. S. and Andrade, S. P. (2001) Mechanisms of angiotensin-(1-7)-induced inhibition of angiogenesis. Am. J. Physiol. Regul. Integr. Comp. Physiol. 280, R994-R1000
48. Gennari-Moser, C., Khankin, E. V., Schuller, S., Escher, G., Frey, B. M., Portmann, C. B., Baumann, M. U., Lehmann, A. D., Surbek, D., Karumanchi, S. A. et al. (2011) Regulation of placental growth by aldosterone and cortisol. Endocrinology 152, 263-271
49. Batenburg, W. W., Jansen, P. M., van den Bogaerdt, A. J. and Danser, A. H. J. (2012) Angiotensin II-aldosterone interaction in human coronary microarteries involves GPR30, EGFR, and endothelial NO synthase. Cardiovasc. Res. 94, 136-143
50. Escher, G., Cristiano, M., Causevic, M., Baumann, M., Frey, F. J., Surbek, D. and Mohaupt, M. G. (2009) High aldosterone-to-renin variants of cyp11b2 and pregnancy outcome. Nephrol. Dial. Transplant. 24, 1870-1875
51. Gallery, E. D., Mitchell, M. D. and Redman, C. W. (1984) Fall in blood pressure in response to volume expansion in pregnancy-associated hypertension (pre-eclampsia): why does it occur? J. Hypertens. 2, 177-182
52. Farese, S., Shojaati, K., Kadereit, B., Frey, F. J. and Mohaupt, M. G. (2006) Blood pressure reduction in pregnancy by sodium chloride. Nephrol. Dial. Transplant. 21, 1984-1987
53. Gennari-Moser, C., Khankin, E. V., Escher, G., Burkhard, F., Frey, B. M., Karumanchi, S. A., Frey, F. J. and Mohaupt, M. G. (2013) Vascular endothelial growth factor-a and aldosterone relevance to normal pregnancy and preeclampsia. Hypertension 61, 1111-1117
54. Siddiqui, A. H., Irani, R. A., Zhang, W., Wang, W., Blackwell, S. C., Kellems, R. E. and Xia, Y. (2013) Angiotensin receptor agonistic autoantibody-mediated soluble fms-like tyrosine kinase-1 induction contributes to impaired adrenal vasculature and decreased aldosterone production in preeclampsia. Hypertension 61, 472-479
55. Buhl, K. B., Friis, U. G., Svenningsen, P., Gulaveerasingam, A., Ovesen, P., Frederiksen-Moller, B., Jespersen, B., Bistrup, C. and Jensen, B. L. (2012) Urinary plasmin activates collecting duct enac current in preeclampsia. Hypertension 60, 1346-1351
56. Brown, M. A., Zammit, V. C., Mitar, D. A. and Whitworth, J. A. (1992) Renin-aldosterone relationships in pregnancy-induced hypertension. Am. J. Hypertens. 5, 366-371
57. Seva-Pessôa, B., van der Lubbe, N., Verdonk, K., Roks, A. J. M., Hoorn, E. J. and Danser, A. H. J. (2012) Key developments in renin-angiotensin-aldosterone system inhibition. Nat. Rev. Nephrol. 9, 26-36
58. Verdonk, K., van Esch, J. H. M, Visser, W., Steegers, E. A., Danser, A. H. J. and van den Meiracker, A. H. (2011) Do angiotensin II type 2 receptors mediate the enhanced angiotensin II constrictor response in pre-eclampsia? Hypertension 58, E40-E41
59. Florijn, K. W., Derkx, F. H., Visser, W., Hofman, J. A., Rosmalen, F. M., Wallenburg, H. C. and Schalekamp, M. A. (1991) Plasma immunoreactive endothelin-1 in pregnant women with and without pre-eclampsia. J. Cardiovasc. Pharmacol. 17, S446-S448
60. Krop, M., Lu, X., Danser, A. H. J. and Meima, M. E. (2013) The (pro)renin receptor. A decade of research: what have we learned? Pflügers Arch. 465, 87-97
61. van den Heuvel, M., Batenburg, W. W., Jainandunsing, S., Garrelds, I. M., van Gool, J. M. G, Feelders, R. A., van den Meiracker, A. H. and Danser, A. H. J. (2011) Urinary renin, but not angiotensinogen or aldosterone, reflects the renal renin-angiotensin-aldosterone system activity and the efficacy of renin-angiotensin-aldosterone system blockade in the kidney. J. Hypertens. 29, 2147-2155
62. Persson, F., Lu, X., Rossing, P., Garrelds, I. M., Danser, A. H. J. and Parving, H. H. (2013) Urinary renin and angiotensinogen in type 2 diabetes: added value beyond urinary albumin? J. Hypertens. 31, 1646-1652